IRCT201205059645N1已完成未知
Comparison of the effect of lithium plus quetiapine with lithium plus risperidone in children and adolescents with bipolar Idisorder (manic or mixed episode) in a double blind randomized clinical trial
niversity of Social Welfare and Rehabilitation Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 10 years 至 17 years（—）
- 性别
- All
入选标准
- •ages 10-17 with bipolar I disorder, manic or mixed episode
- •Exclusion criteria: YMRS score < 20 ( young mania rating scale); mood symptoms secondary to substance intoxication or withdrawal; substance use disorders 3 months prior to study; mental retardation; severe medical diseases; serious neurologic disorders; autistic disorder; history of hypersensitivity or intolerance or nonresponse to quetiapine or risperidone or lithium; use of long acting antipsychotics 3 months prior to study; use of antidepressants or antipsychotics 1 week prior to study; use of psychostimulants or benzodiazepines 72 hours prior to study
排除标准
- 未提供
研究者
相似试验
已完成
3 期
Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I DisorderBipolar DisorderNCT00081380AstraZeneca710
已完成
3 期
Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I DisorderBipolar I DisorderNCT00107731AstraZeneca710
进行中（未招募）
1 期
Comparative Evaluation of QUEtiapine-Lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in patients with bipolar depression - CEQUEBipolar depressionMedDRA version: 13.1 Level: LLT Classification code 10004936 Term: Bipolar depression System Organ Class: 10037175 - Psychiatric disordersEUCTR2007-004513-33-GBniversity of Oxford202
已完成
不适用
Comparative Evaluation of QUEtiapine-Lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in people with bipolar depressioISRCTN17054996niversity of Oxford (UK)202
已完成
4 期
europrotective Properties of Quetiapine versus Lithium in a First Episode Mania Cohort: 12-month Neuroanatomical, Neurochemical and Neuro-cognitive Effects and Preliminary Data of Prophylactic PropertiesFirst episode mania (bipolar and schizoaffective illnesses)Mental Health - Other mental health disordersACTRN12607000639426The University of Melbourne61